Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

A Novel Small Molecule Drug-Based Approach for Treating Beta-Globinopathies

Jun Liu, Ziyang Shen, Yanhua Dong, Na Yu, Li Chai, Daniel G. Tenen, Daniel E. Bauer, Adelaide Herman, Braden Pate, Kim Vanuytsel

Blood (2024) 144 (Supplement 1): 172.

https://doi.org/10.1182/blood-2024-211753

Published: 2024

Journal Articles

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Blood (2023) 142 (Supplement 1): 1295.

https://doi.org/10.1182/blood-2023-181541

Published: 2023

Journal Articles

Genome-Wide Methylation Sensitive Elements Demarcate Targetable Regulatory Elements for Controllable Gene Activation

Yanjing Vera Liu, Jeremiah Suryatenggara, Hannan Wong, Jing Ping Tang, Hong Kee Tan, Junsu Kwon, Qiling Zhou, Simone Ummarino, Alexander Ebralidze, John G. Doench, Li Chai, Touati Benoukraf, Devendra Hiwase, Daniel Thomas, Annalisa Di Ruscio, Daniel G. Tenen, Mahmoud Adel Bassal

Blood (2023) 142 (Supplement 1): 3647.

https://doi.org/10.1182/blood-2023-182715

Published: 2023

Journal Articles

Targeting the Oncofetal Transcription Factor Protein SALL4 in Cancer By a Non-IMiD Degrader

Blood (2023) 142 (Supplement 1): 7144.

https://doi.org/10.1182/blood-2023-184502

Published: 2023

Journal Articles

Ultrasensitive Detection of SALL4 Oncoproteins in Peripheral Blood and Bone Marrow Aspirate: Companion Diagnostics and Therapeutic Monitoring

Sanjana Shah, Jun Liu, Yasmeen Senussi, Arek Melkonian, James Nuhfer, Scott Lovitch, Neal Lindeman, Annette S. Kim, David R. Walt, Li Chai

Blood (2023) 142 (Supplement 1): 6049.

https://doi.org/10.1182/blood-2023-187876

Published: 2023

Journal Articles

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Blood (2023) 142 (12): 1082–1098.

https://doi.org/10.1182/blood.2022018591

Published: 2023

Includes: Supplemental data

Journal Articles

Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression

Ryan Philip Jajosky, Jerry W. Allen, Patricia E Zerra, Cheryl L Maier, Satheesh Chonat, Chance John Luckey, John D. Roback, Ross M. Fasano, Cassandra D. Josephson, John P Manis, Li Chai, Jeanne E. Hendrickson, Krystalyn E Hudson, Connie M. Arthur, Sean R. Stowell

Blood (2022) 140 (Supplement 1): 73–74.

https://doi.org/10.1182/blood-2022-170081

Published: 2022

Journal Articles

Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)

Blood (2021) 138 (Supplement 1): 4757.

https://doi.org/10.1182/blood-2021-147622

Published: 2021

Journal Articles

Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML

Blood (2021) 138 (15): 1331–1344.

https://doi.org/10.1182/blood.2020007920

Published: 2021

Includes: Supplemental data

Journal Articles

Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53

Hiro Tatetsu, MD, Miho Watanabe, MD, Emily F Mason, MD PhD, Scott B Lovitch, MDPhD, Kenji Tokunaga, MD, Eisaku Iwanaga, MD, Masao Matsuoka, MDPhD, Daniel G. Tenen, MD, Li Chai, MD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-134533

Published: 2020

Journal Articles

Early Bortezomib Failure Predicts Shorter PFS: a Retrospective Analysis from 4 Victorian Centres

Krystal Bergin, Thomas E Lew, Annie W.S. Chow, Paul Kopanidis, Hui Yin Lim, Kah Lok Chan, Khai-Li Chai, Chong Chyn Chua, John Reynolds, Andrew Spencer

Blood (2016) 128 (22): 5708.

https://doi.org/10.1182/blood.V128.22.5708.5708

Published: 2016

Journal Articles

Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy

Sumita Ratnasingam, MBBS, Michael Gilbertson, Zoe McQuilten, MBBS, Kay T Htun, George Grigoriadis, MBBS, PhD BSc, Swe Myo Htet, MBBS, Philip Campbell, MBBS, FRACP, FRCPA, Khai Li Chai, MBBS, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Sushrut S. Patil, FRACP, FRCPA, Jake Shortt, MD, Stephen Opat, MD

Blood (2016) 128 (22): 2965.

https://doi.org/10.1182/blood.V128.22.2965.2965

Published: 2016

Journal Articles

Mechanisms of MEF2C-Dependent Transcription in Lymphoid Differentiation

Nikki R. Kong, PhD, Li Chai, MD, Astar Winoto, PhD, Robert Tjian, PhD

Blood (2014) 124 (21): 4341.

https://doi.org/10.1182/blood.V124.21.4341.4341

Published: 2014

Journal Articles

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

Hiro Tatetsu, MD PhD, Fei Wang, Chong Gao, MD PhD, Shikiko Ueno, MD PhD, Xi Tian, BS, Myriam Armant, PhD, Alex Federation, Jun Qi, PhD, James E. Bradner, Daniel G. Tenen, MD, Li Chai, MD

Blood (2014) 124 (21): 1566.

https://doi.org/10.1182/blood.V124.21.1566.1566

Published: 2014

Journal Articles

Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex

Chong Gao, Todor Dimitrov, Kol Jia Yong, Hiro Tatetsu, Ha-won Jeong, Hongbo R. Luo, James E. Bradner, Daniel G. Tenen, Li Chai

Blood (2013) 121 (8): 1413–1421.

https://doi.org/10.1182/blood-2012-04-424275

Published: 2013

Includes: Supplemental data

Journal Articles

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

Hiro Tatetsu, MD, PhD, Chong Gao, MD, PhD, Shikiko Ueno, MD, PhD, Daniel G Tenen, MD, Li Chai, MD

Blood (2012) 120 (21): 2337.

https://doi.org/10.1182/blood.V120.21.2337.2337

Published: 2012

Journal Articles

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Shikiko Ueno, MD, PhD, Jiayun Lu, PhD, He Jie, PhD, Ailing Li, PhD, XiaoXian Zhang, Leslie E Silberstein, MD, Jerome Ritz, MD, Li Chai, MD

Blood (2011) 118 (21): 2428.

https://doi.org/10.1182/blood.V118.21.2428.2428

Published: 2011

Journal Articles

Sall4, a Stem Cell Factor, Promotes Chemoresistance by Regulates the Side Population Cell Phenotype.

Ha-Won Jeong, Wei Cui, Ye Guo, Youyang Yang, Jiayun Lu, MD, PhD, Chong Gao, MD, PhD, Li Chai

Blood (2009) 114 (22): 3093.

https://doi.org/10.1182/blood.V114.22.3093.3093

Published: 2009

Journal Articles

Deletion of Fak in Hematopoietic Stem Cells Leads to Enhanced Engraftment.

Jiayun Lu, Cesar Nombela-Arrieta, Shin-Young Park, Yi Le, Li Chai, Leslie E. Silberstein

Blood (2008) 112 (11): 1407.

https://doi.org/10.1182/blood.V112.11.1407.1407

Published: 2008

Journal Articles

SALL4 is a key regulator of survival and apoptosis in human leukemic cells

Jianchang Yang, Li Chai, Chong Gao, Taylor C. Fowles, Zaida Alipio, Hien Dang, Dan Xu, Louis M. Fink, David C. Ward, Yupo Ma

Blood (2008) 112 (3): 805–813.

https://doi.org/10.1182/blood-2007-11-126326

Published: 2008

Includes: Supplemental data

NARROW

A Novel Small Molecule Drug-Based Approach for Treating Beta-Globinopathies

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Genome-Wide Methylation Sensitive Elements Demarcate Targetable Regulatory Elements for Controllable Gene Activation

Targeting the Oncofetal Transcription Factor Protein SALL4 in Cancer By a Non-IMiD Degrader

Ultrasensitive Detection of SALL4 Oncoproteins in Peripheral Blood and Bone Marrow Aspirate: Companion Diagnostics and Therapeutic Monitoring

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression

Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)

Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML

Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53

Early Bortezomib Failure Predicts Shorter PFS: a Retrospective Analysis from 4 Victorian Centres

Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy

Mechanisms of MEF2C-Dependent Transcription in Lymphoid Differentiation

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Sall4, a Stem Cell Factor, Promotes Chemoresistance by Regulates the Side Population Cell Phenotype.

Deletion of Fak in Hematopoietic Stem Cells Leads to Enhanced Engraftment.

SALL4 is a key regulator of survival and apoptosis in human leukemic cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only